At ASTRO 2018, Accuray showcased new patient-first innovations, including motion synchronization on Radixact, and the new CK VoLO, a fast optimizer on the CyberKnife system.
ASTRO
This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy.
-
-
Restrictive prior authorization practices cause unnecessary delays and interference in care decisions for cancer patients, according to a new survey of nearly 700 radiation oncologists — released by the American Society for Radiation Oncology (ASTRO).
-
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus a peek at the company’s roadmap for the future. Chris highlights: -
Radiation therapy has become increasingly effective and safe as vendors continue to innovate technologies that benefit the patient.
-
Accuray's philosophy is to personalize treatments to exactly fit the patient. Senior Director of Marketing Andrew Delao explains this philosophy in a conversation with Greg Freiherr at ASTRO 2018.
News | Radiation Therapy | May 21, 2019
May 21, 2019 — Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer...
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-...
News | Proton Therapy | May 02, 2019
May 2, 2019 – IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA...
News | Radiation Therapy | April 26, 2019
April 26, 2019 — Restrictive prior authorization practices cause unnecessary delays and interference in care...
News | Oncology Information Management Systems (OIMS) | April 25, 2019
April 25, 2019 – Philips announced IntelliSpace Radiation Oncology, an intelligent...
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
April 24, 2019 — Accuray announced the launch of its Synchrony motion tracking and correction technology to be used...
News | Proton Therapy | April 09, 2019
April 9, 2019 — Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation...
News | Treatment Planning | March 19, 2019
March 19, 2019 — Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated...
News | Proton Therapy | March 13, 2019
March 13, 2019 — The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018,...
News | Treatment Planning | March 08, 2019
March 8, 2019 — Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the...
Technology | Advanced Visualization | February 27, 2019
February 27, 2019 — Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s...
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
News | Radiation Therapy | February 15, 2019
February 15, 2019 – University of Minnesota Health (M Health) is the first in the United States to begin offering...
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
February 7, 2019 — The Elekta Unity...
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
January 31, 2019 — The first report from a phase II, multi-center clinical trial indicates...
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve...
Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The metallic-based nanoparticles show up on CT scans so it can be used as a permanent fiduciary marker to track tumor response. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment. Photo by Dave Fornell
Feature | Radiation Oncology | January 30, 2019 | By Dave Fornell
Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the...
Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus a...
News | Brachytherapy Systems | January 04, 2019
January 4, 2018 — Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-...
